Net Product Revenue

Service Revenue

- Non-OCS Service Revenue

OCS Transplant Revenue

- Lung

- Heart

- Liver

Total Revenue

9fc3af85351ef6979376e46fd0bf59426250b702f36ef78ea21fbdd7b5c777ca

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

dbbd51b1d759c1d3150b3816c9291164b78008d7defb46bdc8e0cd6100b87643

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

456c176f6313aa07413b31adfe89719f45d338444f9fbf1148dd5015cc931b8f

Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

Selling, General, and Administrative Expenses (SG&A) (USD, thousands)

Research and Development (R&D) (USD, thousands)

Depreciation and Amortization (D&A) (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

c2d1f78e5d4f651af326e58482460bb931da35a1be835d3e03375b8a1c2b7178

Cash (USD, thousands)

Accounts receivable (USD, thousands)

Prepaid expenses and other current assets (USD, thousands)

Total current assets (USD, thousands)

Property, plant and equipment, net (USD, thousands)

Operating lease right-of-use assets (USD, thousands)

Restricted cash (USD, thousands)

Acquired intangible assets, net (USD, thousands)

Other non-current assets (USD, thousands)

Total assets (USD, thousands)

Accounts payable (USD, thousands)

Accrued expenses and other current liabilities (USD, thousands)

Deferred revenue (USD, thousands)

Operating lease liabilities (Current) (USD, thousands)

Total current liabilities (USD, thousands)

Convertible senior notes, net (USD, thousands)

Long-term debt, net (USD, thousands)

Operating lease liabilities, net of current portion (USD, thousands)

Total liabilities (USD, thousands)

Common stock (Amount) (USD, thousands)

Accumulated other comprehensive loss (USD, thousands)

Accumulated deficit (USD, thousands)

Total stockholders' equity (USD, thousands)

Total liabilities and stockholders' equity (USD, thousands)

966394c16319fcc639d53ed56dba9cb96d09561af57a3a12461eb74941c7135b

Net income (loss) (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization expense (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Stock-based compensation expense (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Acquired in-process research and development expenses (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Deferred taxes (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Loss on extinguishment of debt (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Loss on sale of marketable securities (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Non-cash interest expense and end of term accretion expense (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Non-cash lease expense (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Net amortization of premiums on marketable securities (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Unrealized foreign currency transaction (gains) losses (USD, thousands)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Loss on disposal of fixed assets (USD, thousands)

Changes in operating assets and liabilities: Accounts receivable (USD, thousands)

Changes in operating assets and liabilities: Inventory (USD, thousands)

Changes in operating assets and liabilities: Prepaid expenses and other current assets (USD, thousands)

Changes in operating assets and liabilities: Other non-current assets (USD, thousands)

Changes in operating assets and liabilities: Accounts payable (USD, thousands)

Changes in operating assets and liabilities: Accrued expenses and other current liabilities (USD, thousands)

Changes in operating assets and liabilities: Operating lease liabilities (USD, thousands)

Net cash provided by (used in) operating activities (USD, thousands)

Cash flows from investing activities: Purchases of property, plant and equipment (USD, thousands)

Cash flows from investing activities: Purchase of business, net of cash acquired (USD, thousands)

Cash flows from investing activities: Purchase of in-process research and development assets (USD, thousands)

Cash flows from investing activities: Purchases of marketable securities (USD, thousands)

Cash flows from investing activities: Proceeds from sales and maturities of marketable securities (USD, thousands)

Net cash provided by (used in) investing activities (USD, thousands)

Cash flows from financing activities: Proceeds from issuance of convertible senior notes, net of issuance costs paid (USD, thousands)

Cash flows from financing activities: Purchases of capped calls related to convertible senior notes (USD, thousands)

Cash flows from financing activities: Proceeds from issuance of long-term debt, net of issuance costs (USD, thousands)

Cash flows from financing activities: Repayments of long-term debt (USD, thousands)

Cash flows from financing activities: Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions and issuance costs paid (USD, thousands)

Cash flows from financing activities: Proceeds from issuance of common stock upon exercise of stock options (USD, thousands)

Cash flows from financing activities: Proceeds from issuance of common stock upon exercise of warrants (USD, thousands)

Cash flows from financing activities: Proceeds from issuance of common stock in connection with employee stock purchase plan (USD, thousands)

Net cash provided by financing activities (USD, thousands)

Effect of exchange rate changes on cash, cash equivalents and restricted cash (USD, thousands)

Net increase (decrease) in cash, cash equivalents and restricted cash (USD, thousands)

Supplemental disclosure of cash flow information: Cash paid for interest (USD, thousands)

Supplemental disclosure of non-cash activities: Transfers of inventory to property, plant and equipment (USD, thousands)

Supplemental disclosure of non-cash activities: Purchases of property, plant and equipment included in accounts payable and accrued expenses (USD, thousands)

Supplemental disclosure of non-cash activities: Operating lease liabilities arising from obtaining right-of-use assets (USD, thousands)

Supplemental disclosure of non-cash activities: Conversion of convertible senior notes into common stock (USD, thousands)

Cash, cash equivalents and restricted cash, beginning of period (USD, thousands)

Transmedics Group Inc (TMDX)

Financials